Chelation Therapy Provides No Benefit Post-MI Chelation Therapy Provides No Benefit Post-MI

Chelation therapy to remove potentially toxic levels of lead was not associated with a reduction in CV events in post-MI patients with diabetes in the TACT2 trial.Medscape Medical News
Source: Medscape Diabetes Headlines - Category: Endocrinology Tags: Cardiology Source Type: news